Parlato M, Charbit-Henrion F, Abi Nader E, et al. Efficacy of ruxolitinib therapy in a patient with severe enterocolitis associated with a STAT3 gain-of-function mutation. Gastroenterology 2019;156:1206–1210.
This entry was posted in News. Bookmark the permalink.